Published in J Biol Chem on June 25, 2008
WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J Bone Miner Res (2011) 1.23
Notch signaling and the bone marrow hematopoietic stem cell niche. Bone (2009) 1.14
Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia. Endocrinology (2008) 1.08
Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice. Endocrinology (2010) 1.02
Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate. J Biol Chem (2010) 1.00
Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis. Endocrinology (2009) 0.97
The role of CCN2 in cartilage and bone development. J Cell Commun Signal (2011) 0.96
HES1 (hairy and enhancer of split 1) is a determinant of bone mass. J Biol Chem (2010) 0.92
Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). Int J Mol Med (2015) 0.88
Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family. J Cell Commun Signal (2012) 0.84
Connective tissue growth factor is a target of notch signaling in cells of the osteoblastic lineage. Bone (2014) 0.80
Notch: A multi-functional integrating system of microenvironmental signals. Dev Biol (2016) 0.78
Connective Tissue Growth Factor reporter mice label a subpopulation of mesenchymal progenitor cells that reside in the trabecular bone region. Bone (2014) 0.78
CCN2 as a novel molecule supporting energy metabolism of chondrocytes. J Cell Biochem (2014) 0.77
Nephroblastoma overexpressed (Nov) induces gremlin in ST-2 stromal cell lines by post-transcriptional mechanisms. J Cell Biochem (2011) 0.76
Connective tissue growth factor (CTGF) transactivates nuclear factor of activated T-cells (NFAT) in cells of the osteoblastic lineage. J Cell Biochem (2010) 0.75
Promotion of Ccn2 expression and osteoblastic differentiation by actin polymerization, which is induced by laminar fluid flow stress. J Cell Commun Signal (2012) 0.75
BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses. PLoS One (2015) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73
RNA interference--2001. Genes Dev (2001) 7.68
Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res (1985) 7.67
HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol (2003) 7.32
In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol (1983) 5.39
Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development (2003) 4.31
Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell (2006) 4.28
Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol (2002) 4.14
Wnt signaling in osteoblasts and bone diseases. Gene (2004) 3.72
Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. Cell (2006) 3.42
The CCN family: a new stimulus package. J Endocrinol (2003) 3.16
The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation. FEBS Lett (1998) 3.00
NFAT and Osterix cooperatively regulate bone formation. Nat Med (2005) 2.99
Marrow stromal stem cells. J Clin Invest (2000) 2.85
Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development (1999) 2.55
Twisted gastrulation is a conserved extracellular BMP antagonist. Nature (2001) 2.50
Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem (2004) 2.35
Integration of Notch 1 and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation control. Dev Cell (2005) 2.21
NFAT signaling in vertebrate development. Curr Opin Genet Dev (2001) 2.15
Effect of primary and secondary structure of oligodeoxyribonucleotides on the fluorescent properties of conjugated dyes. Nucleic Acids Res (2002) 1.98
Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol Cell Biol (1998) 1.98
Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci U S A (1989) 1.98
Proposal for a unified CCN nomenclature. Mol Pathol (2003) 1.98
Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene (2002) 1.88
HERP, a new primary target of Notch regulated by ligand binding. Mol Cell Biol (2001) 1.85
Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem (2003) 1.81
A simple and sensitive histochemical method for calcium. Proc Soc Exp Biol Med (1952) 1.78
Twisted gastrulation can function as a BMP antagonist. Nature (2001) 1.75
Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology (1992) 1.75
Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore. Nucleic Acids Res (2002) 1.72
Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling. J Biol Chem (2006) 1.61
Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development (2004) 1.60
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology (2004) 1.58
Notch 1 impairs osteoblastic cell differentiation. Endocrinology (2003) 1.57
Dual roles for the Notch target gene Hes-1 in the differentiation of 3T3-L1 preadipocytes. Mol Cell Biol (2004) 1.55
Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol (2000) 1.51
Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol (2003) 1.43
Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J Biol Chem (1999) 1.41
Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa. Immunobiology (1997) 1.37
The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells. Mol Endocrinol (2004) 1.37
Expression and regulation of CCN genes in murine osteoblasts. Bone (2005) 1.32
Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia. J Biol Chem (2007) 1.28
Mediation of NGF signaling by post-translational inhibition of HES-1, a basic helix-loop-helix repressor of neuronal differentiation. Genes Dev (1997) 1.28
Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol (1999) 1.27
Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signalling. Development (2003) 1.26
The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Mol Cell Biol (2005) 1.25
Motch A and motch B--two mouse Notch homologues coexpressed in a wide variety of tissues. Exp Cell Res (1993) 1.24
Notch-independent regulation of Hes-1 expression by c-Jun N-terminal kinase signaling in human endothelial cells. Lab Invest (2006) 1.24
CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology (2003) 1.21
Mammalian twisted gastrulation is essential for skeleto-lymphogenesis. Mol Cell Biol (2003) 1.17
Calcineurin regulates bone formation by the osteoblast. Proc Natl Acad Sci U S A (2005) 1.16
Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells. Exp Cell Res (2005) 1.14
Expression of the BMP 2 gene during bone cell differentiation. Crit Rev Eukaryot Gene Expr (1994) 1.04
Functional requirement of CCN2 for intramembranous bone formation in embryonic mice. Biochem Biophys Res Commun (2007) 1.03
Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts. Am J Physiol Endocrinol Metab (2000) 0.94
Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function. Bone (2006) 0.90
Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro. Endocrinology (2005) 0.86
Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res (2007) 3.38
Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev (2008) 2.64
Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord (2006) 2.03
Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab (2006) 1.91
Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology (2008) 1.78
Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling. J Biol Chem (2006) 1.61
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology (2004) 1.58
Notch 1 impairs osteoblastic cell differentiation. Endocrinology (2003) 1.57
PPARG by dietary fat interaction influences bone mass in mice and humans. J Bone Miner Res (2008) 1.50
Notch and the skeleton. Mol Cell Biol (2009) 1.49
A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. Proc Natl Acad Sci U S A (2012) 1.48
A soluble activin type IIA receptor induces bone formation and improves skeletal integrity. Proc Natl Acad Sci U S A (2008) 1.42
Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res (2003) 1.39
The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J Endocrinol (2006) 1.37
Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology (2003) 1.37
The fate of circulating osteoblasts. N Engl J Med (2005) 1.36
Osteoblast lineage-specific effects of notch activation in the skeleton. Endocrinology (2012) 1.32
Expression and regulation of CCN genes in murine osteoblasts. Bone (2005) 1.32
Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. J Bone Miner Res (2009) 1.29
Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia. J Biol Chem (2007) 1.28
Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTLs with sex-dependent regulation of bone phenotypes. J Bone Miner Res (2007) 1.26
Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone (2002) 1.22
CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology (2003) 1.21
Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med (2010) 1.15
CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia. Bone (2006) 1.14
Misexpression of CCAAT/enhancer binding protein beta causes osteopenia. J Endocrinol (2009) 1.14
Conditional deletion of gremlin causes a transient increase in bone formation and bone mass. J Biol Chem (2007) 1.12
Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia. Endocrinology (2008) 1.08
Notch regulation of bone development and remodeling and related skeletal disorders. Calcif Tissue Int (2011) 1.05
Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice. Endocrinology (2010) 1.02
The heparin-binding domain of IGFBP-2 has insulin-like growth factor binding-independent biologic activity in the growing skeleton. J Biol Chem (2011) 1.02
Conditional inactivation of noggin in the postnatal skeleton causes osteopenia. Endocrinology (2012) 1.01
Notch signaling in skeletal health and disease. Eur J Endocrinol (2013) 1.00
Reciprocal regulation of Notch and nuclear factor of activated T-cells (NFAT) c1 transactivation in osteoblasts. J Biol Chem (2010) 0.99
C/EBP homologous protein is necessary for normal osteoblastic function. J Cell Biochem (2006) 0.99
Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. J Biol Chem (2013) 0.98
Cortisol regulates the expression of Notch in osteoblasts. J Cell Biochem (2002) 0.97
Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis. Endocrinology (2009) 0.97
A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis. J Endocrinol (2009) 0.97
AU-rich elements in the collagenase 3 mRNA mediate stabilization of the transcript by cortisol in osteoblasts. J Biol Chem (2003) 0.95
HES1 (hairy and enhancer of split 1) is a determinant of bone mass. J Biol Chem (2010) 0.92
Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity. Biochem Pharmacol (2003) 0.92
The mutation ROR2W749X, linked to human BDB, is a recessive mutation in the mouse, causing brachydactyly, mediating patterning of joints and modeling recessive Robinow syndrome. Development (2008) 0.92
Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss. Curr Osteoporos Rep (2009) 0.91
Effects of activated T cells on osteoclastogenesis depend on how they are activated. Bone (2004) 0.90
Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function. Bone (2006) 0.90
Role of MT1-MMP in the osteogenic differentiation. Bone (2008) 0.89
Gremlin1 is required for skeletal development and postnatal skeletal homeostasis. J Cell Physiol (2012) 0.89
Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor. Am J Physiol Lung Cell Mol Physiol (2014) 0.88
Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics (Sao Paulo) (2010) 0.87
Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro. Endocrinology (2005) 0.86
Notch suppresses nuclear factor of activated T cells (NFAT) transactivation and Nfatc1 expression in chondrocytes. Endocrinology (2012) 0.86
Nuclear factor of activated T-cells (NFAT)C2 inhibits Notch receptor signaling in osteoblasts. J Biol Chem (2012) 0.86
Gene delivery by retroviruses. Methods Mol Biol (2008) 0.85
BMD regulation on mouse distal chromosome 1, candidate genes, and response to ovariectomy or dietary fat. J Bone Miner Res (2011) 0.84
Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice. J Biol Chem (2013) 0.82
Activation of the ERK pathway in osteoblastic cells, role of gremlin and BMP-2. J Cell Biochem (2008) 0.82
Loss of gremlin delays primordial follicle assembly but does not affect female fertility in mice. Biol Reprod (2011) 0.81
Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity. J Bone Miner Res (2014) 0.81
Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation. Bone (2010) 0.81
Bone morphogenetic protein-2 suppresses collagenase-3 promoter activity in osteoblasts through a runt domain factor 2 binding site. J Cell Physiol (2005) 0.81
Role of the RAM domain and ankyrin repeats on notch signaling and activity in cells of osteoblastic lineage. J Bone Miner Res (2006) 0.80
Activation of Nfatc2 in osteoblasts causes osteopenia. J Cell Physiol (2015) 0.79
Nemo-like kinase inhibits osteoblastogenesis by suppressing bone morphogenetic protein and WNT canonical signaling. J Cell Biochem (2012) 0.79
Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease. Autoimmun Rev (2003) 0.78
Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. Arq Bras Endocrinol Metabol (2007) 0.78
Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates. Inflamm Bowel Dis (2013) 0.77
Treatment of glucocorticoid-induced osteoporsis. Ther Adv Musculoskelet Dis (2009) 0.76
Nephroblastoma overexpressed (Nov) induces gremlin in ST-2 stromal cell lines by post-transcriptional mechanisms. J Cell Biochem (2011) 0.76
Transcriptional regulation of collagenase-3 by interleukin-1 alpha in osteoblasts. J Cell Biochem (2003) 0.76
11beta-hydroxysteroid dehydrogenase, an amplifier of glucocorticoid action in osteoblasts. J Bone Miner Res (2002) 0.76
Connective tissue growth factor (CTGF) transactivates nuclear factor of activated T-cells (NFAT) in cells of the osteoblastic lineage. J Cell Biochem (2010) 0.75
Nemo-like kinase regulates postnatal skeletal homeostasis. J Cell Physiol (2014) 0.75
Transgenic overexpression of gremlin results in developmental defects in enamel and dentin in mice. Connect Tissue Res (2008) 0.75
Bone Morphogenetic Proteins Induce Gremlin, a Protein That Limits Their Activity in Osteoblasts* *This work was supported by NIAMSD Grant AR-21707. Endocrinology (2000) 0.75